INS and Hypertension: The mechanism for hypertension in this study is unclear and may arise from copanlisib-mediated inhibition of PI3K at the endothelial level leading to vasoconstriction [20], or through insulin-dependent vasoconstriction [21] as an effect of the post-infusion hyperglycemia, or both.